https://www.selleckchem.com/pr....oducts/way-316606.ht
37 to -9.317, P = 0.00 and of the low-density lipoprotein-cholesterol (LDL-C) (WMD -17 mg/dL, 95% CI -25.77, -8.22, P = 0.00. In the stratified analysis, a significant decrease of serum triglycerides (TG) (WMD -22.06 mg/dL) was achieved in the RCTs with a duration of ≤ 26 weeks (WMD -8.70 mg/dL) and with baseline TG concentrations of ≥ 130 mg/dL (WMD -23.02 mg/dL). In conclusion, raloxifene treatment can increase HDL-C and lower LDL-C and TC. In terms of TG, a significant decrease can be observed if the administration of raloxife
Curtir
Comentario
Compartilhar
